GEMCITABINE

作品数：313被引量：907H指数：11
导出分析报告
相关领域：医药卫生更多>>
相关作者：贾林巴一黄鼎智韩如冰李鸿立更多>>
相关机构：中山大学广州医学院天津医科大学广州市第一人民医院更多>>
相关期刊：更多>>
相关基金：国家自然科学基金中国博士后科学基金广东省社会发展领域科技计划项目国家重点基础研究发展计划更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=Journal of Cancer Therapyx
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Prolonged Infusion of Low Dose Gemcitabine in Advanced Pancreatic Carcinoma
《Journal of Cancer Therapy》2020年第7期401-409,共9页Elsayed Mostafa Ali Ahmed M. Maklad Salah M. Khallaf 
Background: Gemcitabine was established as a monotherapy or in combination for locally advanced or metastatic pancreatic carc...
关键词：GEMCITABINE Pancreatic Cancer Intravenous Infusion LOW-DOSE 
In Frail Elderly Patients, Low-Dose Gemcitabine over 6-Hour Infusion Is Equally Effective and Less Toxic Than the Standard Gemcitabine Protocol for Advanced Pancreatic Adenocarcinoma: A Randomized Phase II Trial被引量：1
《Journal of Cancer Therapy》2020年第3期124-141,共18页Salah Mabrouk Khallaf Elsayed Mostafa Ali Ahmed MMaklad Mohamed Medhat Samir Anwar Tawfik Amin Muhammad Abbas El-masry Mona MSayed Dalia Osama 
Background:?Treatment of frail elderly patients with pancreatic cancer is still a major problem due to intolerance to standard chemotherapy doses. Aim:?This study aims to compare the low-dose gemcitabine over 6 hours ...
关键词：Continuous INFUSION Elderly FRAIL Low Dose GEMCITABINE PANCREATIC Cancer 
Concomitant Chemoradiation Using Gemcitabine in Locally Advanced Hepatocellular Carcinoma
《Journal of Cancer Therapy》2018年第12期1027-1038,共12页Mohamed-Alaa-Eldeen H. Mohamed 
Purpose: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Most of patients present with advanced disease that cannot be treated with curative or ablative intent. The aim of the study was to ...
关键词：CHEMORADIATION GEMCITABINE Hapatocellular CARCINOMA SURVIVAL 
Fixed Dose Rate versus Standard Dose Rate Infusion of Gemcitabine and Cisplatin in Advanced Stage Non-Small Cell Lung Cancer被引量：1
《Journal of Cancer Therapy》2015年第1期45-52,共8页Dina A. Salem Dina R. Ibrahim Ahmed Ezzat Azza M. Adel 
Background: Comparing the efficacy and safety of gemcitabine at a fixed-dose rate (FDR) infusion (10 mg/m2/min) with the standard dose rate infusion in patients with locally advanced and metastatic non-small squamous ...
关键词：NON-SMALL Cell Lung Cancer GEMCITABINE Fixed-Dose Rate TOXICITIES 
Simultaneous Dual Selective Targeted Delivery of Two Covalent Gemcitabine Immunochemotherapeutics and Complementary Anti-Neoplastic Potency of [Se]-Methylselenocysteine被引量：1
《Journal of Cancer Therapy》2015年第1期62-89,共28页C. P. Coyne Toni Jones Ryan Bear 
The anti-metabolite chemotherapeutic, gemcitabine is relatively effective for a spectrum of neoplastic conditions that include various forms of leukemia and adenocarcinoma/carcinoma. Rapid systemic deamination of gemc...
关键词：GEMCITABINE ANTI-EGFR Anti-HER2/neu Covalent Immunochemotherapeutic Gemcitabine-(C4-amide)-[Anti-EGFR] Gemcitabine-(C4-amide)-[Anti-HER2/neu] Mammary Adenocarcinoma (SKBr-3) [Se]-Methylselenocysteine 
Chemotherapy (Gemcitabine plus Carboplatin versus Paclitaxel plus Carboplatin) in Elderly Patients with Non-Small Cell Lung Cancer
《Journal of Cancer Therapy》2014年第3期281-296,共16页Takanori Ayabe Masaki Tomita Eiichi Chosa Makoto Ikenoue Yukie Shirasaki Kunihide Nakamura 
Background: This retrospective study was to evaluate the efficacy and toxicity of gemcitabine plus carboplatin (GC regimen) and paclitaxel plus carboplatin (PC regimen) combination chemotherapy in elderly patients wit...
关键词：ELDERLY Lung Cancer CHEMOTHERAPY PACLITAXEL GEMCITABINE CARBOPLATIN 
Impact of ABO Blood Types on Survival after Pancreatectomy for Pancreatic Cancer
《Journal of Cancer Therapy》2013年第10期7-12,共6页Tadashi Kayashima Masafumi Nakamura Kenoki Ohuchida Syunichi Takahata Kohei Nakata Naoki Ikenaga Lin Cui Shingo Kozono Kazuhiro Mizumoto Masao Tanaka 
Background/Purpose: A recent genome-wide association study (PanScan) identified significant association between the ABO gene locus and the risk of pancreatic cancer. The aim of this study was to analyze survival of pa...
关键词：Pancreatic Cancer ABO Blood Type SURVIVAL GEMCITABINE ADJUVANT Chemotherapy 
Adjuvant Chemotherapy of Gemcitabine plus Carboplatin versus Paclitaxel plus Carboplatin in Patients with Resected Non-Small Cell Lung Cancer被引量：1
《Journal of Cancer Therapy》2013年第8期15-23,共9页Takanori Ayabe Masaki Tomita Kunihide Nakamura 
Background: This retrospective study was to evaluate the efficacy and toxicity of gemcitabine plus carboplatin (GC regimen) and paclitaxel plus carboplatin (PC regimen) combination chemotherapy administered as an adju...
关键词：NON-SMALL Cell Lung Cancer GEMCITABINE PACLITAXEL CARBOPLATIN Combination Chemotherapy ADJUVANT Therapy 
Pemetrexed and Gemcitabine for Chemotherapy Refractory Colorectal Cancer—Results of a Phase II and Translational Research Study
《Journal of Cancer Therapy》2013年第6期44-50,共7页Karen-Lise Garm Spindler Niels Pallisgaard Rikke Fredslund Andersen John Ploen Anders Jakobsen 
Introduction: We investigated the safety and efficacy of pemetrexed with gemcitabine in heavily pre-treated, chemotherapy refractory, KRAS mutated colorectal cancer (mCRC) and the prognostic value of quantitative leve...
关键词：METASTATIC COLORECTAL Cancer KRAS cfDNA Plasma PEMETREXED GEMCITABINE 
Practical Use of Gemcitabine and Cisplatin Combination Therapy as First-Line Treatment for Japanese Patients with Advanced Biliary Tract Cancer
《Journal of Cancer Therapy》2013年第6期1068-1073,共6页Hisato Kawakami Isamu Okamoto Wataru Okamoto Masayuki Takeda Shinya Ueda Toshihiro Kudo Shin-ichi Nishina Yasuhito Fujisaka Masaki Miyazaki Junji Tsurutani Takayasu Kurata Kazuhiko Nakagawa 
Gemcitabine and cisplatin combination therapy (GC) is accepted as a standard treatment for advanced biliary tract cancer (BTC). However, little information is available regarding such treatment in the clinical practic...
关键词：GEMCITABINE CISPLATIN CHEMOTHERAPY BILIARY TRACT Cancer 
全选清除导出
共2页<12>
检索报告 对象比较 聚类工具 使用帮助 返回顶部